Predict your next investment

Government
grants.nih.gov/grants/funding/qtdp_pim/index.htm

See what CB Insights has to offer

Investments

251

Portfolio Exits

108

About Qualifying Therapeutic Discovery Project

The Qualifying Therapeutic Discovery Project program was designed to promote medical research by providing tax credits and grants to small firms that show potential to produce new therapies, reduce long-term health care costs, or advance the goal of curing cancer within the next 30 years. The credit or grant covers up to 50 percent of the cost of qualifying biomedical research, up to a maximum credit of $5 million per firm and $1 billion overall, and is only available to firms with no more than 250 employees.

Qualifying Therapeutic Discovery Project Headquarter Location

Washington, DC,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Qualifying Therapeutic Discovery Project News

Xylos Corporation Awarded U.S. Grant Qualifying Therapeutic Discovery Project (QTDP) Program.

Aug 3, 2018

Xylos Corporation ("Xylos" or the "Company"), a leader in biocellulose technology for medical applications, announced recently that the Company was awarded a grant in the amount of $244,479 under the U.S. Xylos' application was focused on its innovative biomaterial solutions for the treatment, repair and replacement of human tissue. Among various eligibility guidelines, a QTDP applicant was required to demonstrate reasonable potential for its project to result in new therapies to treat areas of

Qualifying Therapeutic Discovery Project Investments

251 Investments

Qualifying Therapeutic Discovery Project has made 251 investments. Their latest investment was in Savara as part of their Grant - II on May 5, 2011.

CBI Logo

Qualifying Therapeutic Discovery Project Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/16/2011

Grant - II

Savara

$0.24M

Yes

12/28/2010

Grant - II

Kythera Biopharmaceuticals

$0.24M

No

12/27/2010

Grant - II

Groove Biopharma

$0.1M

No

12/23/2010

Grant

Subscribe to see more

$99M

Subscribe to see more

0

12/21/2010

Grant

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/16/2011

12/28/2010

12/27/2010

12/23/2010

12/21/2010

Round

Grant - II

Grant - II

Grant - II

Grant

Grant

Company

Savara

Kythera Biopharmaceuticals

Groove Biopharma

Subscribe to see more

Subscribe to see more

Amount

$0.24M

$0.24M

$0.1M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Qualifying Therapeutic Discovery Project Portfolio Exits

108 Portfolio Exits

Qualifying Therapeutic Discovery Project has 108 portfolio exits. Their latest portfolio exit was ALung Technologies on May 05, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/5/2022

Acquired

$99M

2

2/22/2022

Acquired

$99M

3

10/29/2021

IPO

$99M

Public

10

10/8/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/18/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/5/2022

2/22/2022

10/29/2021

10/8/2021

6/18/2021

Exit

Acquired

Acquired

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

3

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.